New data on the effectiveness of Paxlovid against COVID

 New data on the effectiveness of Paxlovid against COVID

< /p>

Maccabi Health Insurance Fund conducted a survey among coronavirus patients who took Pfizer's Paxlovid.

According to The Jerusalem Post, 92% of patients who took the drug reported a significant improvement in their health.

In addition, the study showed that 6% of patients stopped drinking the drug due to side effects.

Add a Comment

Your email address will not be published.